Eidos Therapeutics
What matters now
- 1 investornamed
1 investor on record.
The investors already on the cap table shape who leads the next round.
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- unknown
- Rounds on record
- 1
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 1
Financing history
- Mar 29, 2018Form D equity offering · $26.0M (form d sold)RA Capital Management, LP via Rajeev ShahFact Form D · “Eidos Therapeutics, Inc. Form D, first filed 2018-04-12”
Investors on record
- RA Capital Management, LP portfolio listing Fact racap.com
- RA Capital Management, LP form d related, Rajeev Shah (strongly supported) Inference sec.gov
Ownership and outcomes
How these are wordedA company a buyout or growth firm lists on its own site is “listed in the portfolio of”, never “acquired by”. A date prints only when a deal record gives one; otherwise the row says when DFX first saw it.Listed on 1 firm portfolio page; none states an outcome (acquired, public, exited or active). DFX does not assume the company is active.
Evidence: 1 listingeach firm's own card, as read
- Status not stated on RA Capital Management, LP · the firm's card prints no outcome · read Oct 1, 2026 racap.com“Eidos Therapeutics”
Credit relationships
How a loan is matchedA BDC reports its loans by borrower name. A position shows here only when the match passed a precision gate (a hand-labelled sample was 29 of 30 correct); the tier and confidence are printed on each row. Amounts are the lender’s reported position, never a round.People
Timeline
Evidence
Every observation on this company
- Listed on portfolio page: RA Capital Management, LP Oct 1, 2026 Fact Firm website
- Listed on portfolio page: RA Capital Management, LP Sep 16, 2026 Fact Firm website
- Listed on portfolio page: RA Capital Management, LP Sep 15, 2026 Fact Firm website